Cargando…
miR-630 Inhibits Epithelial-to-Mesenchymal Transition (EMT) by Regulating the Wnt/β-Catenin Pathway in Gastric Cancer Cells
Despite availability of different treatments, gastric cancer remains the second highest cause of cancer-related deaths worldwide. This study was aimed to explore the role of miR-630 in gastric cancer by investigating the underlying mechanism of inhibiting epithelial-to-mesenchymal transition (EMT) o...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848419/ https://www.ncbi.nlm.nih.gov/pubmed/29422112 http://dx.doi.org/10.3727/096504018X15178732625479 |
_version_ | 1783645132408487936 |
---|---|
author | Li, Dong Tian, Bo Jin, Xiaosheng |
author_facet | Li, Dong Tian, Bo Jin, Xiaosheng |
author_sort | Li, Dong |
collection | PubMed |
description | Despite availability of different treatments, gastric cancer remains the second highest cause of cancer-related deaths worldwide. This study was aimed to explore the role of miR-630 in gastric cancer by investigating the underlying mechanism of inhibiting epithelial-to-mesenchymal transition (EMT) of SGC-7901 and BGC-823 cells through the Wnt/β-catenin pathway. Results showed that miR-630 was downregulated in several gastric cancer cell lines, including SGC-7901 and BGC-823. Transfection of miR-630 mimic showed a significant decrease in wound healing in a scratch assay in both cell lines compared to a scramble group. Also, transfection of miR-630 mimic inhibited cell viability, migration, and invasion of gastric cancer cells. miR-630 mimic transfection suppressed EMT by activating the Wnt/β-catenin pathway. This was supported by the fact that miR-630-mediated suppression of the EMT phenotype was reversed in the presence of the Wnt/β-catenin inhibitor ICG001. miR-630 plays a protective role against gastric cancer by suppressing EMT through activating the Wnt/β-catenin pathway. |
format | Online Article Text |
id | pubmed-7848419 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Cognizant Communication Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-78484192021-02-16 miR-630 Inhibits Epithelial-to-Mesenchymal Transition (EMT) by Regulating the Wnt/β-Catenin Pathway in Gastric Cancer Cells Li, Dong Tian, Bo Jin, Xiaosheng Oncol Res Article Despite availability of different treatments, gastric cancer remains the second highest cause of cancer-related deaths worldwide. This study was aimed to explore the role of miR-630 in gastric cancer by investigating the underlying mechanism of inhibiting epithelial-to-mesenchymal transition (EMT) of SGC-7901 and BGC-823 cells through the Wnt/β-catenin pathway. Results showed that miR-630 was downregulated in several gastric cancer cell lines, including SGC-7901 and BGC-823. Transfection of miR-630 mimic showed a significant decrease in wound healing in a scratch assay in both cell lines compared to a scramble group. Also, transfection of miR-630 mimic inhibited cell viability, migration, and invasion of gastric cancer cells. miR-630 mimic transfection suppressed EMT by activating the Wnt/β-catenin pathway. This was supported by the fact that miR-630-mediated suppression of the EMT phenotype was reversed in the presence of the Wnt/β-catenin inhibitor ICG001. miR-630 plays a protective role against gastric cancer by suppressing EMT through activating the Wnt/β-catenin pathway. Cognizant Communication Corporation 2018-12-27 /pmc/articles/PMC7848419/ /pubmed/29422112 http://dx.doi.org/10.3727/096504018X15178732625479 Text en Copyright © 2019 Cognizant, LLC. http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is licensed under a Creative Commons Attribution-NonCommercial NoDerivatives 4.0 International License. |
spellingShingle | Article Li, Dong Tian, Bo Jin, Xiaosheng miR-630 Inhibits Epithelial-to-Mesenchymal Transition (EMT) by Regulating the Wnt/β-Catenin Pathway in Gastric Cancer Cells |
title | miR-630 Inhibits Epithelial-to-Mesenchymal Transition (EMT) by Regulating the Wnt/β-Catenin Pathway in Gastric Cancer Cells |
title_full | miR-630 Inhibits Epithelial-to-Mesenchymal Transition (EMT) by Regulating the Wnt/β-Catenin Pathway in Gastric Cancer Cells |
title_fullStr | miR-630 Inhibits Epithelial-to-Mesenchymal Transition (EMT) by Regulating the Wnt/β-Catenin Pathway in Gastric Cancer Cells |
title_full_unstemmed | miR-630 Inhibits Epithelial-to-Mesenchymal Transition (EMT) by Regulating the Wnt/β-Catenin Pathway in Gastric Cancer Cells |
title_short | miR-630 Inhibits Epithelial-to-Mesenchymal Transition (EMT) by Regulating the Wnt/β-Catenin Pathway in Gastric Cancer Cells |
title_sort | mir-630 inhibits epithelial-to-mesenchymal transition (emt) by regulating the wnt/β-catenin pathway in gastric cancer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848419/ https://www.ncbi.nlm.nih.gov/pubmed/29422112 http://dx.doi.org/10.3727/096504018X15178732625479 |
work_keys_str_mv | AT lidong mir630inhibitsepithelialtomesenchymaltransitionemtbyregulatingthewntbcateninpathwayingastriccancercells AT tianbo mir630inhibitsepithelialtomesenchymaltransitionemtbyregulatingthewntbcateninpathwayingastriccancercells AT jinxiaosheng mir630inhibitsepithelialtomesenchymaltransitionemtbyregulatingthewntbcateninpathwayingastriccancercells |